News | January 06, 2022
ENTOD Pharmaceuticals set to launch Molentod
It is the generic version of molnupiravir
It is the generic version of molnupiravir
Tangent offers ISO/IEC 17025-accredited calibrations and has labs located in both Indianapolis and Huntsville, Alabama
Healthy growth in domestic and emerging markets is expected to support revenue growth in the next few quarters
The product is expected to be available in a week’s time
Natco Pharma has received approval for Covid 19 drug molnupiravir capsules 200 mg. for Indian market, which will be sold under brand name Molnunat
Flattish volume growth and subdued new launches were key factors for last month
After specialising in laparoscopy, proctology, urology, and cosmetic surgeries, Glamyo Health is now venturing into orthopaedic surgeries
During H1 FY2022, the revenues and operating profit margin (OPM) for ICRA sample set showed sharp improvement aided by volume uptick in Covid-19 and allied tests and also demand traction for non-Covid tests
_256_384.jpg)
Ind-Ra expects IPM revenue growth of over 12% yoy for FY22.
The multi-target agreement covers five programmes focused on off-the-shelf vaccines for cancer and infectious disease
Subscribe To Our Newsletter & Stay Updated
